Stat6 null phenotype human lymphocytes exhibit increased apoptosis

Journal of Surgical Research

Volumn 122, Issue 1, 2004, Pages 14-20

  Galka, Eva ^a   Thompson, Jennifer Lynn ^a   Zhang, Wen Jie ^a   Poritz, Lisa S ^a   Koltun, Walter A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

apoptosis; infammatory bowel disease (IBD); Stat6 null

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LIPOCORTIN 5; NEUTRALIZING ANTIBODY; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL LINE; CONTROLLED STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING; WILD TYPE;

ANTIBODIES; APOPTOSIS; CELL LINE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTES; PHENOTYPE; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 7444226266     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.05.004     Document Type: Article

References (24)

1. D.K. Podolsky Inflammatory Bowel Disease N. Eng. J. Med. 347 2002 417
2. T. MacDonald, P. Hutchings, M. Choy, S. Murch, A. Cooke Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine Clin. Exp. Immunol. 81 1990 301
3. S. Schreiber, S. Nikolaus, J. Hampe Activation of nuclear factor kappa B in inflammatory bowel disease Gut 42 1998 477
4. K. Isaacs, R. Sartor, S. Haskill Cytokine messenger RNA profiles in Inflammatory Bowel Disease mucosa detected by polymerase chain reaction amplification Gastroenterology 103 1992 1587
5. G. Monteleone, T.T. MacDonald, N.C. Wathen, F. Pallone, S.L.F. Pender Enhancing lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury Gastroenterology 117 1999 1069
6. M. Boirivant, M. Marini, G. Di Felice, A.M. Pronio, C. Montesani, R. Tersigni, W. Strober Lamina propria T cells in Crohn's Disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis Gastroenterology 116 1999 557
7. K. Nelms, A.D. Keegan, J. Zamorano, J.J. Ryan, W.E. Paul The IL-4 receptor signaling mechanisms and biologic functions Annu. Rev. Immunol. 17 1999 701
8. W.J. Zhang, J.L. Thompson, M.J. Chorney, W.A. Koltun Phenotyping of IL-4-induced Stat6 activity in humans quantification after gel shift assay using immortalized cell lines Oncol. Rep. 10 2003 1281
9. W. Koltun, L. Poritz, A. Tilberg, S. Boehmer, M. Page, S. Ort, W. Zhang The creation of a highly uniform, familial inflammatory bowel disease (IBD) registry (RF6) Dis. Colon Rectum 44 2001 A2
10. J.L. Caputo, A. Thompson, P. McClintock, Y.A. Reid, R.J. Hay An effective method for establishing human B lymphoblastic cell lines using Epstein-Barr virus J. Tissue Cult. Meth. 13 1991 39
11. W.J. Zhang, W.A. Koltun, A.F. Tilberg, J.L. Thompson, M.J. Chorney Genetic control of interleukin-4-induced activation of the human signal transducer and activator 6 signaling pathway Hum. Immunol. 64 2003 402
12. T.L. Rothstein Inducible resistance to Fas-mediated apoptosis in B cells Cell Res. 10 2000 245
13. I.J. Fuss, T. Marth, M.F. Neurath, G.R. Pearlstein, A. Jain, W. Strober Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice Gastroenterology 117 1999 1078
14. I.J. Fuss, M. Neurath, M. Boirivant, J.S. Klein, C. de la Motte, S.A. Strong, C. Fiocchi, W. Strober Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J. Immunol. 157 3 1996 1261
15. B.L. Bennett, R. Cruz, R.G. Lacson, A.M. Manning Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription Is mediated by STAT6 antagonism of NF-kappaB J. Biol. Chem. 272 1997 10212
16. R.A. Seder, W.E. Paul, M.M. Davis, B. Fazekas de St. Groth The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice J. Exp. Med. 176 1992 1091
17. M.K. Levings, J.W. Schrader IL-4 Inhibits the production of TNF-alpha and IL-12 by Stat6-dependent and independent mechanisms J. Immunol. 162 1999 5224
18. M. Altomonte, C. Pucillo, G. Damante, M. Maio Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-α by the EBV-B lymphoblastoid cell line JY J. Immunol. 151 1993 5115
19. E. Kilger, A. Kieser, M. Baumann, W. Hammerschmidt Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor EMBO J. 17 1998 1700
20. J. Zamorano, A.E. Kelly, J. Austrian, H.Y. Wang, A.D. Keegan Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner Implications for cell survival and proliferation Cell Res. 11 2001 44
21. A.K. Kacha, F. Fallarino, M.A. Markiewicz, T.F. Gajewski Cutting edge spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice J. Immunol. 165 2000 6024
22. S. Ostrand-Rosenberg, M.J. Grusby, V.K. Clements Cutting Edge STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma J. Immunol. 165 2000 6015
23. Y. Ohmori, T. Hamilton STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages J. Biol. Chem. 273 1998 29202
24. L.M. Stamm, A. Räisänen-Sokolowski, M. Okano, M.E. Russell, J.R. David, A.R. Satoskar Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis J. Immunol. 161 1998 6180